Free Trial

EssilorLuxottica Société anonyme (ESLOY) Stock Forecast & Price Target

EssilorLuxottica Société anonyme logo
$130.68 +4.58 (+3.63%)
As of 03:59 PM Eastern

EssilorLuxottica Société anonyme - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
0

Based on 1 Wall Street analysts who have issued ratings for EssilorLuxottica Société anonyme in the last 12 months, the stock has a consensus rating of "Hold." Out of the 1 analysts, 1 has given a hold rating for ESLOY.

Consensus Price Target

N/A

Get the Latest News and Ratings for ESLOY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for EssilorLuxottica Société anonyme and its competitors.

Sign Up

ESLOY Analyst Ratings Over Time

TypeCurrent Forecast
1/22/24 to 1/21/25
1 Month Ago
12/23/23 to 12/22/24
3 Months Ago
10/24/23 to 10/23/24
1 Year Ago
1/22/23 to 1/22/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
N/A
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
N/A
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
N/A
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Hold
Hold
N/A
Hold

ESLOY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ESLOY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

EssilorLuxottica Société anonyme Stock vs. The Competition

TypeEssilorLuxottica Société anonymeMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.82
2.52
Consensus RatingHoldModerate BuyModerate Buy
Predicted UpsideN/A24,741.04% Upside12.44% Upside
News Sentiment Rating
Positive News

See Recent ESLOY News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/3/2024UBS Group
4 of 5 stars
S. Tibaldi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
10/2/2023Royal Bank of Canada
4 of 5 stars
 UpgradeUnderperform ➝ Sector Perform
4/17/2023Sanford C. Bernstein
3 of 5 stars
 DowngradeOutperform ➝ Market Perform
4/13/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 08:10 PM ET.


Should I Buy EssilorLuxottica Société anonyme Stock? ESLOY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, January 14, 2025. Please send any questions or comments about these EssilorLuxottica Société anonyme pros and cons to contact@marketbeat.com.

EssilorLuxottica Société anonyme
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in EssilorLuxottica Société anonyme:

  • The current stock price is $120.67, which reflects a stable trading environment and may indicate potential for growth.
  • EssilorLuxottica Société anonyme has a diverse product portfolio, including well-known brands like Ray-Ban and Oakley, which can attract a wide customer base and drive sales.
  • The company operates in multiple regions, including Europe, North America, and Asia-Pacific, providing a broad market reach and reducing dependency on any single market.
  • Recent analyst ratings indicate a shift in perception, with UBS Group recently downgrading the stock to a "neutral" rating, which may suggest that the stock is currently overvalued, presenting a potential buying opportunity for investors looking for a rebound.
  • EssilorLuxottica Société anonyme is involved in both manufacturing and direct-to-consumer sales, allowing for better control over its supply chain and customer relationships, which can enhance profitability.

EssilorLuxottica Société anonyme
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in EssilorLuxottica Société anonyme for these reasons:

  • The stock has recently experienced a decline of 0.5%, which may indicate underlying issues or market sentiment that could affect future performance.
  • Trading volume has decreased by 22% from the average, suggesting reduced investor interest and potential liquidity issues, which can make it harder to buy or sell shares without affecting the stock price.
  • Analyst downgrades can often lead to negative sentiment in the market, and the recent downgrade from UBS Group may deter potential investors from entering the stock.
  • As a company operating in the personal services industry, EssilorLuxottica Société anonyme may face challenges from economic downturns that affect consumer spending on eyewear and related products.
  • The competitive landscape in the eyewear market is intense, with numerous brands vying for market share, which could pressure margins and impact profitability.

ESLOY Forecast - Frequently Asked Questions

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for EssilorLuxottica Société anonyme in the last twelve months. There is currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ESLOY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ESLOY, but not buy additional shares or sell existing shares.

According to analysts, EssilorLuxottica Société anonyme's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, EssilorLuxottica Société anonyme's stock had 1 downgrade by analysts.

EssilorLuxottica Société anonyme has been rated by research analysts at UBS Group in the past 90 days.

Analysts like EssilorLuxottica Société anonyme less than other "medical" companies. The consensus rating for EssilorLuxottica Société anonyme is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ESLOY compares to other companies.


This page (OTCMKTS:ESLOY) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners